Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes

Journal of Clinical Investigation

Volumn 123, Issue 8, 2013, Pages 3363-3372

  Warszawska, Joanna M ^a,b   Gawish, Riem ^a,b   Sharif, Omar ^a,b   Sigel, Stefanie ^a,b   Doninger, Bianca ^a,b   Lakovits, Karin ^b   Mesteri, Ildiko ^a   Nairz, Manfred ^c   Boon, Louis ^d   Spiel, Alexander ^a   Fuhrmann, Valentin ^a   Strobl, Birgit ^e   Müller, Mathias ^e   Schenk, Peter ^a   Weiss, Günter ^c   Knapp, Sylvia ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Laboratory of Infection Biology   (Portugal)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d BIOCEROS   (Netherlands)

^e UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BRONCHOSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREGULATION; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; SURVIVAL;

ACUTE-PHASE PROTEINS; ADULT; AGED; ANIMALS; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; LIPOCALINS; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; ONCOGENE PROTEINS; PNEUMONIA, PNEUMOCOCCAL; PROTO-ONCOGENE PROTEINS; TRANSPLANTATION CHIMERA;

EID: 84881232123     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67911     Document Type: Article

References (56)

1. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723-737.
2. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35.
3. Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med. 2008;358(7):716-727.
4. Mitchell TJ. Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res Microbiol. 2000;151(6):413-419.
5. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374(9700):1543-1556.
6. Lagler H, et al. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol. 2009;183(3):2027-2036.
7. Knapp S, et al. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med. 2003;167(2):171-179.
8. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992; 176(1):287-292.
9. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958-969.
10. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677-686.
11. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549-555.
12. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268(14):10425-10432.
13. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83(3):799-807.
14. Flo TH, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917-921.
15. Chan YR, et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol. 2009;182(8):4947-4956.
16. Berger T, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2006;103(6):1834-1839.
17. Nairz M, et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood. 2009;114(17):3642-3651.
18. Saiga H, et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol. 2008;181(12):8521-8527.
19. Tettelin H, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001;293(5529):498-506.
20. Nelson AL, Barasch JM, Bunte RM, Weiser JN. Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol. 2005; 7(10):1404-1417.
21. Park S, Guo J, Kim D, Cheng JQ. Identification of 24p3 as a direct target of Foxo3a regulated by interleukin- 3 through the phosphoinositide 3-kinase/ Akt pathway. J Biol Chem. 2009;284(4):2187-2193.
22. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11(11):750-761.
23. Nelson AL, Ratner AJ, Barasch J, Weiser JN. Interleukin- 8 secretion in response to aferric enterobactin is potentiated by siderocalin. Infect Immun. 2007;75(6):3160-3168.
24. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol. 2008;22(6):1416-1426.
25. Ehrt S, et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med. 2001;194(8):1123-1140.
26. Weiss G, Werner-Felmayer G, Werner ER, Grunewald K, Wachter H, Hentze MW. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med. 1994;180(3):969-976.
27. Oexle H, et al. Pathways for the regulation of interferon- gamma-inducible genes by iron in human monocytic cells. J Leukoc Biol. 2003;74(2):287-294.
28. Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science. 2001;293(5531):829-834.
29. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 1996;174(5):994-1000.
30. van der Sluijs KF, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol. 2004;172(12):7603-7609.
31. Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med. 2009;15(3):277-284.
32. Kayama H, et al. Intestinal CX3C chemokine receptor 1high (CX3CR1high) myeloid cells prevent T-cell-dependent colitis. Proc Natl Acad Sci U S A. 2012;109(13):5010-5015.
33. Whiteaker JR, et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol. 2011;29(7):625-634.
34. Jung M, et al. Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth. Mol Cell Biol. 2012;32(19):3938-3948.
35. Vizzardelli C, et al. Effects of dexamethazone on LPSinduced activationand migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur J Immunol. 2006;36(6):1504-1515.
36. Recalcati S, et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol. 2010;40(3):824-835.
37. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol. 2006;80(6):1298-1307.
38. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10(5):1033-1043.
39. Yang J, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell. 2002;10(5):1045-1056.
40. Devireddy LR, Gazin C, Zhu X, Green MR. A cellsurface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell. 2005; 123(7):1293-1305.
41. Bachman MA, Miller VL, Weiser JN. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog. 2009;5(10):e1000622.
42. Srinivasan G, et al. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxininduced sepsis. J Immunol. 2012;189(4):1911-1919.
43. Charlson ES, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184(8):957-963.
44. Bachman MA, et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun. 2011; 79(8):3309-3316.
45. Zhang X, Majlessi L, Deriaud E, Leclerc C, Lo-Man R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity. 2009; 31(5):761-771.
46. Jung M, et al. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2. Kidney Int. 2012;81(10):969-982.
47. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277.
48. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol. 2001;21(5):1621-1632.
49. Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer SJ, van der Poll T. TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol. 2001;167(9):5240-5246.
50. Knapp S, et al. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia. J Infect Dis. 2004;189(8):1506-1515.
51. Knapp S, et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol. 2004;172(5):3132-3138.
52. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. Curr Protoc Immunol. 2008;Chapter 14:Unit14.1.
53. Raoust E, Balloy V, Garcia-Verdugo I, Touqui L, Ramphal R, Chignard M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS One. 2009;4(10):e7259.
54. Draing C, et al. Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae. J Biol Chem. 2006;281(45):33849-33859.
55. Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med. 2001; 193(3):393-397.
56. Brightbill HD, Plevy SE, Modlin RL, Smale ST. A prominent role for Sp1 during lipopolysaccharidemediated induction of the IL-10 promoter in macrophages. J Immunol. 2000;164(4):1940-1951.